Prix Breakthrough 2026 : lauréats

Destinataires

1. Albert Maguire, Jean Bennett, Katherine A. High

   Biologie

   For developing a therapy for inherited retinal degeneration that became the first FDA-approved gene therapy for a genetic disease.

2. Bryan Traynor, Rosa Rademakers

   Biologie

   For the discovery of the most common genetic cause of ALS and frontotemporal dementia which charted the path for new mechanistic studies of these diseases.

3. Stuart H. Orkin, Swee Lay Thein

   Biologie

   For elucidating the mechanism driving the switch from fetal to adult hemoglobin and validating it as a therapeutic target for sickle-cell disease and beta-thalassemia.